White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling ...

This summer, we will start a Phase II study evaluating a combination of Lutikizumab and our anti CD40 Ravagalimab in rheumatoid arthritis. And Scott Reents, AbbVie's СFO, pleased me with the ...

As Dix points out, pharma reluctantly developed antibodies to treat severe inflammatory diseases such as rheumatoid arthritis because ... the psoriasis pill Otezla (apremilast).

Oral medication apremilast (Otezla) was approved in 2014 for clinically active ... It was already approved for rheumatoid arthritis (RA) and for one subtype of juvenile idiopathic arthritis (JIA).

Suzy Katz's knee pain was so bad that she had trouble walking long distances. For years, it was blamed on Lyme disease, ...

Rheumatoid arthritis is less common than osteoarthritis, affecting around 514,000 Australians. It mostly impacts the wrists ...

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back ...

This study found elevated rates of carpal tunnel syndrome in patients diagnosed with rheumatoid arthritis years later, ...